Skip to main content

Peer Review reports

From: Pre-clinical study of IRDye800CW-nimotuzumab formulation, stability, pharmacokinetics, and safety

Original Submission
29 Sep 2020 Submitted Original manuscript
30 Dec 2020 Author responded Author comments - Wendy Bernhard
17 Nov 2020 Reviewed Reviewer Report - Helmout Modjtahedi
25 Nov 2020 Reviewed Reviewer Report
Resubmission - Version 2
30 Dec 2020 Submitted Manuscript version 2
28 Feb 2021 Author responded Author comments - Wendy Bernhard
18 Jan 2021 Reviewed Reviewer Report - Helmout Modjtahedi
18 Feb 2021 Reviewed Reviewer Report
Resubmission - Version 3
28 Feb 2021 Submitted Manuscript version 3
Publishing
2 Mar 2021 Editorially accepted
12 Mar 2021 Article published 10.1186/s12885-021-08003-3

You can find further information about peer review here.

Back to article page
\